Icon

AVYCAZ (nda206494)- (EQ 0.5GM BASE;2GM/VIAL)

AVIBACTAM SODIUM; CEFTAZIDIME ABBVIE
EQ 0.5GM BASE;2GM/VIAL
Yes Yes
2032-Jun-15 2020-Feb-25
None None
2025-Feb-25 No
AVYCAZ (ceftazidime-avibactam) is a combination of a cephalosporin and a beta-lactamase inhibitor indicated for the treatment of patients 18 years or older with the following infections caused by designated susceptible microorganisms: • Complicated Intra-abdominal Infections (cIAI), used in combination with metronidazole • Complicated Urinary Tract Infections (cUTI), including Pyelonephritis.
0 0 0
Total Other Developers 5
Drugs with Suitability No
EQ 0.5GM BASE;2GM/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.